Medistim Forecast, price target & analysts
Medistim Target price 2024 - Analyst rating & recommendation
Medistim Classifications & Recommendation:
Medistim Price Target
| Target Price | NOK190.00 |
| Price | NOK180.00 |
| Potential |
5.56%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Medistim price target 2025.
The average Medistim target price is NOK190.00.
This is
5.56%
register free of charge
|
|
| A rating was issued by 2 analysts: 1 Analysts recommend Medistim to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Medistim stock has an average upside potential 2025 of
5.56%
register free of charge
|
Sales and Margin forecast 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million NOK | 521.11 | 562.00 |
| 7.17% | 7.85% | |
| EBITDA Margin | 28.76% | 30.07% |
| 8.55% | 4.57% | |
| Net Margin | 19.96% | 20.62% |
| 15.20% | 3.32% |
2 Analysts have issued a sales forecast Medistim 2024 . The average Medistim sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Medistim EBITDA forecast 2024. The average Medistim EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Medistim 2024 . The average Medistim net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share NOK | 5.68 | 6.33 |
| 9.12% | 11.44% | |
| P/E | 28.44 | |
| EV/Sales | 5.71 |
1 Analysts have issued a Medistim forecast for earnings per share. The average Medistim <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Medistim stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
